V BRYAN LAWLIS

CIK 1247681 · last filed 2025-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.87M

Companies

6

Total Filings

78

Lifetime Open-Market Net

-$9.50M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GERN Director 13,300 $1.15 $15.3K -$220.6K 16 2025-05-22
BMRN Director 33,140 $55.95 $1.85M -$9.28M 45 2023-05-24
Spyre Therapeutics, Inc. (AGLE) Delisted Director $12.01 $0 5 2022-06-09
CHRS Director $1.40 $0 10 2021-01-13
STRO Director $28.80 $0 1 2018-09-27
HUMANIGEN, INC (KBIO) Delisted Director $0 1 2013-09-03

Recent Filings · Page 3 of 8

78 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-06-09 BMRN Sell (S) −4,430 -$476.0K EDGAR
2020-06-09 GERN Grant (A) $0 EDGAR
2020-05-29 BMRN Grant (A) +4,300 $0 EDGAR
2020-03-18 BMRN Mixed −4,610 -$554.8K EDGAR
2020-01-14 CHRS Grant (A) $0 EDGAR
2019-12-19 BMRN Mixed -$231.9K EDGAR
2019-09-18 BMRN Mixed -$198.6K EDGAR
2019-06-19 BMRN Mixed -$223.4K EDGAR
2019-06-07 GERN Grant (A) $0 EDGAR
2019-06-07 Spyre Therapeutics, Inc. (AGLE) Delisted Grant (A) $0 EDGAR
Showing 2130 of 78
Page 3 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.